A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults and Adolescents
Clinical trial NCT04535453 · COMPLETED
Trial details
- NCT number
- NCT04535453
- Sponsor
- Janssen Vaccines & Prevention B.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-28
- Primary completion
- 2022-03-09
- Enrollment
- 635
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.